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In the pharmaceutical manufacturing process, it is well known that flowing agents such as
MgSt and Cab-O-Sil widely affect critical flow properties that influence the finished
product performance of oral dosage tablets. Though the effects of flowing agents are
beneficial to some extent, the sensitivity of the pharmaceutical formulation to process
shearing of flowing agents during blending can be catastrophic which often results in
product and batch failures. Hence it is essential to study the concentration of flowing agents
and chemical nature of active pharmaceutical ingredients (API) with respect to applied
process shear on formulations. Previous studies have shown that new nanostructures form
as a result of mechanical stress, which alter the intermediate powder properties such as
hydrophobicity, powder flow, and electrostatics. These in turn influence critical properties
such as the tablet hardness, friability, and drug release. While the robust nature of
formulation is determined by its ability to match standard processing speeds during
compression, defects and batch failures are often mistakenly linked to a lack of a particular
flowing agent in the blend. The greatest unknown during the processing of pharmaceutical
powders is how the uniformity, extent, and amount of nanostructures formed at contact
surfaces on the API and carrier particles influence critical properties. The primary aim is
to address this gap in a systematic fashion by focusing on the shear and scale dependence
of lubrication and its impact critical blend performance. In the first stage of the research,
the investigation sought to understand whether the formation of nanostructures was due to
applied process shear. In the second stage, the incorporation of nanocharacterization
techniques to characterize whether the change in flowing agent concentration affected the
rate of formation of new nanostructures. Subsequently in the third stage, the focus sought
to correlate how nanodeposits influence powder density, particle porosity, and flow.
Statistical analysis of the identified process input variables in correlation to key responses
measured by pharmaceutical companies, in terms of product performance validation. This
analysis was used to identify significant interactions and effects that may help scientists
better understand the mechanistic rate behind the formation of nanosmears at contact
particle surfaces during blending of pharmaceutical ingredients with flowing agents.
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1. INTRODUCTION
Tablets are the desired means of drug delivery compared to other delivery mechanisms;
such as aerosol, editable film, transdermal, and intravenous delivery. Compared to the other
methods for drug delivery, tablets are less costly to manufacture, simple to administer, and can
deliver a precise dosage to the intended recipient. Roughly 80% of the pharmaceutical products
produced come in tablets or capsules that have been blended from bulk powder materials
(Boukouvala et al., 2012). However, the drawback to tablets is that the activation and drug
release is more prolonged, ultimately affecting the bioavailability of the therapeutic drug.
Today, the pharmaceutical industry relies heavily on batch modified processes to produce
solid pharmaceutical drugs. This is due to the need to ensure production is fast, cost effective,
and quality controlled. Utilizing batch driven processing to ensure quality control provides
pharmaceutical companies with the necessary reassurance to comply with strict regulatory
standards set forth by various governmental agencies. Batch driven processing can ensure
quality control is maintained throughout the various processing steps. A few of these steps
include raw material handling, dispensing, milling, mixing, compression, coating, and
packaging. However, what’s often a troublesome case with batch processes is the number of
potential problems that arise from scale up implementation of unit operations from the laboratory
to the full scale processing plant; the difficulties to produce a homogeneous and fluidized
powder; and the lack of understanding from how the nature of the Carrier and API interaction
influences critical properties relating to product performance (Plumb, 2005). Because of the
above problems incurred in the batch processing of pharmaceutical materials, pharmaceutical
manufacturing produces products that often have a large amount of variability and
unaccountability of how minuet process characteristics can result in the acceptance or rejection
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of a batch of product (Boukouvala et al., 2012). Even high shear mixing curtailed to a specific
mixing order has created prolonged product development issues as there is a significant lack of
knowledge of how critical material attributes can lead to large scale batch failures (McKenzie et
al., 2006). In this context, the complexity of physical phenomena during high shear mixing
affecting such large scale batch failures is poorly understood in the most recent years.
Furthermore, new products are pulled out of production if the product fails to conform to quality
standards on the manufacturing order filed with the FDA. Since the change control process with
the FDA to fix processing issues through formulation modification can take years for product
recertification, there is significant interest to understand how minute adjustments in blending or
compression can bring a formulation back to quality conformance. Despite the recent
advancements in studying the powder behavior (A. Mehrotra et al., 2007a; Shah et al., 1977),
lack of fully developed quantitative techniques to address the impact of nanoscopic phenomena
points to a strong need to enhance the Quality by Design of pharmaceuticals. The development
of new novel techniques that can characterize deviations in the pharmaceutical blend, which can
be reconciled early on in the pharmaceutical manufacturing process to correct critical factors
influencing product performance variability, is the foundation of this thesis.

1.1
1.2

Project Definition

Project Objectives and Scope

Previous work has shown that new nanostructures formed as a result of mechanical stress
alter the intermediate critical blend properties which scale up to drastically to impact tablet
performance properties. To date, the uniformity and extent of nanostructures have been poorly
understood. Furthermore, the question of whether or not the nanostructures interact with carrier
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particles, either affecting cohesion or stability degradation, is not completely understood. To
address this gap, the work will explore the scale dependence of lubrication and its impact on
critical blend properties. To tackle this gap, the work is divided amongst three different
milestones.
The first task is to assess whether the rate of formation of nanostructures is due to applied
process shear on the powders during mixing. In the second stage, an investigation assessed the
scale dependence of flowing agents added to the blends, to see if chemical composition
influences the rate of formation of nanostructures. This stage evaluates how mixing order and
maintained strain on flowing agent components affect nanostructure smearing and composition.
Subsequently in the third stage, the work evaluates characterized nanodeposits assessed with
conventional microscopy techniques to understand how the granular structure influences
nanostructures, powder density, and flow. Addressing the question of scale up influences from
nanosmear formation is a complicated study for future work. An instance of the influence on
nanosmear formation as it imparts key drug performance parameters will be demonstrated
through two commonly measured tablet critical quality parameters (CQP): dissolution and
hardness. Additionally investigating how characterized nanostructure formations influence
microstructure, mesostructure, nanostructure, thickness, and density of tablets will be studied.
The primary goal of this work is to provide a scientific mechanistic understanding to describe the
formation and variation of nanostructures in pharmaceutical powders that will emphasize their
need for consideration in processing and handling of pharmaceutical powders.
Multiple pharmaceutical formulations of both lubricated and un-lubricated blends will be
prepared and mixed in a v-blender under variable shear and fixed strain conditions to
characterize the formation of microstructures and nanostructures on excipient particles within a
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pharmaceutical blend. The changes in powder properties and surface topography throughout the
various blends can be attributed to these formations of nanostructures, which is the focus of this
study. These nanostructures will be characterized using Scanning Electron Microscopy (SEM)
with Electron Dispersive Spectroscopy (EDS) mapping. While the uniformity and extent of
coverage on the API particle interface controls the powder flowability, only a fraction of the
MgSt lubricant used in the flowing agent formulation coats the API surface and forms the
nanostructure. The powder flowability of the blends will be quantified in a gravitational
displacement rheometer (GDR). Past work has shown that the extent of coating for the Cab-OSil was non-uniformly distributed on the API and much weaker than MgSt, which can be
attributed to the interaction between the coating and the API particle surface. The variations in
uniformity, extent of coating, and characteristic nanostructure formation in the powders are key
parameters that will influence tablet performance and bioavailability, which has wide
applications for enhancing the quality by design in pharmaceutical manufacturing.

1.3
1.3.1

Background

Pharmaceutical Ingredients Comprising a Blend
Raw material handling is an essential operation in the manufacture of pharmaceutical

products. The ingredients comprising the blend have to be carefully considered when
determining which route to take in the processing of the pharmaceutical material to the finished
product. Of the different unit operation pathways available in the processing of pharmaceuticals,
the three major pathways are identified as Direct Compression, Wet Granulation, and Dry
Granulation. While granulation of ingredients before blending and compression is well
understood to improve powder flow properties, blend uniformity, and reduce solid dosage form
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defects, the scope of this thesis will focus on the materials and ingredients necessary for direct
compression of the blend. The necessity of choosing the right combination of ingredients for the
pharmaceutical dosage form is to ensure that the pharmaceutical formulation doesn’t stick,
doesn’t cap in the press, runs to the speed of the press, has less than 2% RSD, and provides
hardness and dissolution conforming to quality standards. The goal in blending ingredients is to
process the pharmaceutical powder in as few steps as possible. Powders that do not flow,
compress, eject, or dissolve will require more unit operations to process the final product.
Limiting deviations in densification, flow, compressibility, and ejection are therefore
accomplished by understanding the nature, mixing, and scale dependency of the raw materials
used in the formulation.
A pharmaceutical powder is ideally blended to achieve uniform distribution of the drug
amongst the bulk carrier, which will effectively control the delivery of the drug to the patient.
Since the processing of pharmaceutical ingredients requires transfer from totes, feeder hoppers,
conical mills, and ejection from the press, flowing agents for a pharmaceutical powder are
required to ensure the blend uniformly distributes the active ingredient in the end product to
control dosage. More importantly, the active pharmaceutical ingredient (API) does not satisfy
the consumer’s sense of taste, which is why a carrier helps to reduce direct contact of the API
with the consumer’s senses. Furthermore, a formulation typically only requires milligrams of the
API in the design of a solid dosage form, so the carrier makes the transport the pharmaceutical
into the GI tract more manageable. The primary components comprising the pharmaceutical
blend are therefore the API and excipient. Under the excipient, there are different classes, which
include the binder, filler, compression aid, color, sweetener, coating, disintegrant, lubricant, and
glidant.
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The active ingredient is the most important component of a tablet’s formulation
responsible for treating or alleviating a symptom of concern in the recipient. For this research,
the API chosen for the study is an Acetaminophen blend found in Tylenol™. Acetaminophen is
known to be a mild pain reliever, fever reducer, and headache remedy used in the Tylenol™
drug. The active ingredient dosage is typically specific to the recipient’s physical characteristics
and not necessarily a person’s biological immune system, which will alter the bioavailability of
the active ingredient for treatment.
Excipients comprise the majority of a tablet’s formulation and include vastly comprise
the carrier and binder for the active ingredient. Filler agents, carriers, and binders help form the
complex matrix that enables controlled release to be possible. Lubricants make up between
0.25% to 1% of the pharmaceutical blend, but never more than 1% of the formulation.
Increasing the lubricant concentration is known to increase the hydrophobicity of the both the
blend and tablet which result in irreversible performance validation consequences. Specifically,
one consequence is prolonged drug release in tablet dissolution, which ultimately limits the
bioavailability of the API for therapeutic treatment. When a pharmaceutical product fails to
meet targets for drug release or extended release specifications on the manufacturing card, the
batch is often destroyed, resulting in a waste of manpower, machine time, materials, and money.
Lubricants are primarily used in the formulation to reduce adhesion forces and friction between
the wall and dye during tableting manufacture. Lubricants therefore influence both the physical
properties of a powder and the physiochemical properties of the tablet, making them an
important factor of study in understanding tribological behavior in different pharmaceutical
blends.
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The lubricant associated with this blend is Magnesium Stearate, which has the ability to
coat particles and decrease adhesive particle interaction, making it a very effective lubricant.
Specifically, lubricants are intended to help with the speed and quality by which pharmaceutical
powders are processed through the turrets on a rotary press. Without lubricants, pharmaceutical
powders experience very high ejection forces coming out of the ejection cams, which leads to
quality defects including capping, lamination, picking, and shearing. Glidants on the other hand
are responsible for reducing the electrostatic forces that arise from friction out of particle-particle
or particle-wall interactions. Most powder particles exhibit a great degree of polarity which
inhibits mixing efficiency due to static buildup. The choice of an appropriate glidant is to
mitigate this polarity and improve uniformity during mixing. The chosen glidant for this work
will be Cab-O-Sil, which is a fine granular silica based ingredient with a large particle surface
area to help reduce charge accumulation in the powders. A large unknown in oral dosage drug
delivery is how the glidants, carriers, and lubricants interact with the active ingredient to impact
drug release. Lubricants and glidants are hydrophobic in nature, and can slow drug dissolution
and diffusion controlled mass transfer of the active ingredient into the liquid phase. The
compressive force applied to these tablets during their manufacture can impact properties of
tablet porosity, hardness, and surface energy characteristics, which will also influence the rate of
the diffusion of the solid dosage into the liquid phase.

1.3.2

The Fundamentals of Nanosmearing
Nanosmearing refers to the phenomena of material deposition to a particle surface during

varying degrees of mixing. The rate at which material becomes transferred to either a larger
carrier or API particle is dependent on the shear of ingredients during blend lubrication. In
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Figure 1, the fundamental of nanosmearing occurs when low yield strength particles come in
contact with a larger particle surface. At the moment of contact, interparticle friction results in
the transfer of mass from the particle of lower yield strength to the more rigid material. In the
case of nanosmears observed in this research, nanosmears formed from Magnesium Stearate and
Cab-O-Sil create different structures on the larger particle surface to influence Van der Waals
and Electrostatic properties. Even localized clusters of nanosmears form different characteristic
structures with different orders of mixing of the flowing agents. The different size distributions
of nanosmears being formed on the particle surface provide evidence that surface characteristics
of the nanosmear govern the growth, distribution, and development of the nanosmear layer
during mixing. The physical structure of the nanosmear created when flowing agents are
deposited to the carrier and API particle surfaces is influenced therefore by the size and yield
strength of the flowing agent during mixing.

Figure 1: Nanosmearing Phenomena
8

Two different characteristic structures are formed when the excipients Cab-O-Sil and
Magnesium Stearate are added to the blend. The flowing agent Cab-O-Sil is an agglomeration of
nanoparticles with low yield strength that deposits a cluster of the agglomeration during contact
friction with the carrier particle surface. These can be viewed under an SEM as very small,
spherical particles covering the larger particle surface. The lubricant MgSt is a highly friable
platelet with low yield strength that transfers a portion of its mass to the thin-film nanolayer
when contact friction with the excipient particle surface is experienced. Under an SEM, MgSt
forms a smear on the particle surface, conforming to the shape definition of its host particle. The
strength of these layers has shown that CS forms a much stronger layer to the particle surface,
while the thin-film nanolayer of MgSt forms a very weak and friable smear which can be broken
away with enough particle shear friction.
These shear induced nanosmears hold to the particle surface from Van der Waals
attraction between the large particle surface and the smaller flowing agent smear. Since the
force of attraction is a magnitude larger than the mass of the nanosmear, a very strong bond
between the smear and the particle surface has been known to form (Yu et al., 2003). In the
opposite sense, a cluster of hydrophobic smears on the contact particle surface can significantly
influence interparticle forces. These forces originate from the cluster of smears, where
Electrostatic repulsion forces can keep carrier and API particles from closing to a distance where
Van der Waals forces will take hold to impart better powder bulk density. In this sense, the
control of shear induced nanosmears becomes pivotal towards reducing macro-scale drug
performance variability.
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2. LITERATURE REVIEW
2.1

Scale Dependence of Mixing Order and Lubrication in the Blend

In the pharmaceutical manufacturing process, it is well known that lubricants and
glidants, such as MgSt and Cab-O-Sil, widely affect critical blend properties, such as the flow
indices, hydrophobicity, bulk density, and drug release of the oral dosage tablets (Amit Mehrotra
et al., 2007b; K. Pingali et al., 2011b; Vasilenko et al., 2011). Though the effects of flowing
agents are beneficial for two reasons, limiting the cohesion of the granules to the tooling and
improving granular flow properties to some extent (Moody et al., 1981), sensitivity to shear of
flowing agents can be catastrophic to product performance, resulting in product and batch
failures. Understanding the relationship between scale dependence, mixing order, and sensitivity
to shear of the lubricant are essential to filling in the gap, formed from the scale-up, between the
laboratory development of a drug and its full-scale manufacture.
Mixing of pharmaceutical flowing agents has long been suspected to coat the individual
API and excipient particles in the blend (Shah et al., 1977). Preconditioning excipient and API
powders by mixing independently has shown altercations in surface structure that influence
cohesion at contact surfaces (Podczeck, 1998). Mixing of flowing agents into the pharmaceutical
preblend, comprising the API and carrier(s), has long been performed by a trial and error
approach to determine the optimum mixing order (Wang et al., 2010), duration (Kikuta et al.,
1994), and intensity (Kushner et al., 2010). Increases in blending time, lubricant concentration,
and intensity of mixing of pharmaceutical ingredients has been shown to impact physical
performance properties of manufactured tablets, such as reductions in hardness (Mitrevej et al.,
1982). While a trial and error approach of optimizing the mixing of pharmaceutical ingredients
with flowing agents has proved successful to an extent, the mechanistic formation of these
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surface coatings, known to be nanosmears, is not well understood. During scale up
implementation from lab mixers to pilot scale blenders, evidence has shown that lubricants coat
pharmaceutical particles to a greater extent in large scale batch mixers than laboratory mixers at
similar operational parameters (Otsuka et al., 2009). A thorough understanding of surface
interactions from the structural arrangement of nanodeposited flowing agents on contact particle
surfaces in the pharmaceutical blend is therefore essential to prevent over lubrication of blends in
large scale mixers and provide optimal tribological tablet performance.

2.2

Effect of Shear on Tablet Properties and Drug Performance

A review of the literature does support that the order of mixing of glidants and lubricants
in the pharmaceutical pre-blend do influence the formation of nanostructures that affect critical
and tablet properties (Llusa et al., 2013). Not only is the mixing order and scale dependence of
lubricant dependent on the critical blend properties, but equally significant is the influence of
shear and strain during the blending of the pharmaceutical formulation. In this sense, common
laboratory simulation of shear during the blending of pharmaceuticals has been performed in
either a Couette Shear Rheometer or traditional V-blender with an intensifier bar. While the
instruments to characterize flowability of sheared powders can vary, Vasilenko et al compared
the flowability of different sheared powders assessed using a FT4 Powder Remoter by Freeman
Tech (Malvern, Worcestershire, UK) in comparison to a Gravitational Displacement Rheometer
(GDR) (Vasilenko et al., 2011). The results from Vasilenko’s experimentation showed that the
both instruments ranked the 14 pharmaceutical blends with varying shear and strain conditions in
the same order of flowability. However, with the FT4, the powders exhibited a higher degree of
compressibility and high RSD at low shear. (Vasilenko et al., 2011).
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Mehrotra et al performed a comparison study between a MCC Couette Shear Rheometer,
which provides uniform shear conditions between two concentric plates, and a V-blender. The
disadvantage to the Couette is that it provides poor axial mixing of the powders, thus requiring a
very uniformly mixed preblend prior to the experimentation. The experimentation assessed the
influence of shear rate at 1, 10, 40, 80, 160, and 245rpm at different shear conditions from 267 to
400 shear units for blends containing 0% to 2% lubrication. Mehrotra et al’s results indicate that
improved homogeneity of the blend was achieved at low RSD with increased shear. From the
testing, Mehrotra discovered that the shear rate has a smaller effect on lubricated blend’s RSD
than total strain. (Amit Mehrotra et al., 2007b).

2.3

Incorporating Nanotechnological Characterizations into Pharmaceuticals

With a large growth in demand of pharmaceuticals, the application of nanotechnology
into pharmaceutical systems has seen a growing interest in the study of microparticles,
nanoparticles, nanofibers, nanoemulsions, solid lipid nanoparticles, nanocarriers, and more. In
particular, the synthesis of pharmaceutical drugs into crystalline nanosuspensions has revitalized
many of the promising pharmaceuticals born from the drug discovery programs that were
rejected due to their poor water solubility and limited bioavailability (Rabinow, 2004).
However, in today’s pharmaceutical processing, API are formulated into crystalline structures to
provide increase surface area to volume ratio and stability (Wu et al., 2011). This provides
enhanced drug effectiveness through increased in-vitro and in-vivo bioavailability
With the development of any novel drug or delivery method, there are systematic gaps in
the capabilities of producing therapeutic delivery to the target site, the stability of the drug
particles at the target site, and the understanding of the biological affects the drug particles will
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have on the surrounding tissues and organs (Gaumet et al., 2008). To explain the phenomena of
the unknown interactions taking place on the nanoscale, there is a high demand to develop novel
technologies and methods to characterize the performance and behavior of nanostructures that
influence particle to particle interactions. Therefore, the establishment of techniques and
equipment to characterize nanostructures as a measure of deviation troubleshooting at the batch
production scale is seeing a considerable increase in demand. The promise provided by these
highly analytical tools and techniques allows manufacturing of pharmaceuticals to overcome
common issues arising from drug design, synthesis, stability, scale-up, and performance (Qiu et
al., 2008). The advent of developing the pharmaceutical manufacturing into a highly
technological enterprise does stem from the Federal Drug Administration (FDA) to increase
productivity Overall, the need for pharmaceutical processes to become more efficient, reliable,
and productive has become more apparent with the onset of Quality by Design (QbD) and
Process Analytical Technology (PAT) (Muzzio et al., 2002). These practices are driving the
development of efficient manufacturing practices and reliable manufacturing processes in the
industry today.
To meet the criteria of QbD, the implementation of multi-scale process modeling has
focused on treating the powder at three different scales of quantification: particle, powder, and
dosage form (tablet, capsule, etc.). The growth of multi-scale process modeling arose from the
lack of a mechanistic understanding to incorporate experimental design, optimization, and
multivariate data analysis in a manner that would connect process parameters and material
properties to product quality attributes (Boukouvala et al., 2012; Hamad et al., 2010). The
application of predictive modeling allows properties of the active pharmaceutical ingredient and
the excipients to be assessed at the particle, powder, and dosage scales. At the particle level, the

13

primary focuses for characterizations are with solubility, dissolution rate, hydrophobicity, and
degree of crystallinity. At the powder scale, the primary characterizations focus on powder flow,
bulk density, and compressibility. At the final level, the dosage form, the critical process
parameters involve the dissolution rate, hardness, and weight variability. (Hamad et al., 2010).
To generate these multi-scale process models, understanding how nanosmears influence
the performance parameters between the particle, powder, and dosage scale are critical for
successful predictions. To date, product recalls of pharmaceutical products occur due to three
reasons: the lack of API uniformity in the dosage form, inconsistent or undesired rate of drug
release, or too high of an impurity level creating undesired side effects to the general population.
All these reasons are flaws from a methodological and scientific lack of understanding of the
change in property parameters with pharmaceutical processing (Hamad et al., 2010).

2.4

Surface Modification of Powders to Improve Critical Properties

Surface modifications to API and excipient components comprising the pharmaceutical
blend have been studied to improve flowability (Ghoroi et al., 2013a), bulk density (Han et al.,
2013; Jallo et al., 2012), tablet compaction (van Veen et al., 2005), and blend compressibility
critical properties (More et al., 2013). Surface modified powders during the pre-processing of
API and excipients using Magnetically Assisted Impaction Coating (MAIC) and Fluid Energy
Milling (FEM) have shown that coating the particle surface increases fluidization of the bulk
powder from the reduction of interparticle forces that govern particle instability and performance
behavior after compaction (Ghoroi et al., 2013b; Han et al., 2013; Jallo et al., 2012).
In previous work, the order of mixing of glidants and lubricants in the pharmaceutical
preblend was found to influence the formation of nanostructures that affect critical blend and
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tablet properties (K. Pingali et al., 2013b). Three factors that are critical to the blend properties
were found to be the mixing order, scale of lubricant/glidant, and level of shear and strain
applied during the blending. Between shear and strain however, it was reported that applied
shear has a smaller influence on the lubricated blend’s RSD than total strain (Amit Mehrotra et
al., 2007b). Previously, it was shown that varying the addition of flowing agents while
maintaining consistent strain conditions during the mixing of pharmaceutical powders had a
significant influence on tablet properties (K. Pingali et al., 2011a, 2011b). It is intuitive to argue
that the changes in tribological powder behavior and tablet performance previously seen were
significantly due to the formation of different nanosmeared structures created by different orders
of mixing flowing agents with the pharmaceutical ingredients.
Previous work has also shown that new nanostructures formed as a result of mechanical
stress alter the intermediate critical blend properties which in turn affect tablet performance
properties (K. Pingali et al., 2013b). Until recently, the uniformity, extent of nanostructures, and
their composition have been poorly understood. How nanostructures interact with excipient
particles that can affect the blend’s cohesion tendencies or stability is not completely understood.
To address this gap, this thesis explores whether the physical and chemical nature of nanosmears
formed on excipient and API particles influences physiochemical properties of the blend and
solid dosage form performance. Subsequently, the work also focuses on the characterization of
nanodeposits affecting the granular nanostructure, powder density, and flow. The purpose of this
work is to provide a scientific mechanistic understanding to describe the formation of
nanostructure during different orders of mixing that influence critical blend and tablet properties.
Subsequently, we investigate how the formation of nanostructure from different orders of mixing
influences hardness, porosity, and drug release in tablets.
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3. EXPERIMENTAL METHODOLOGY
Multiple pharmaceutical formulations of both lubricated and un-lubricated blends were
prepared and mixed in a v-blender under variable shear conditions at a constant strain to
characterize the formation of microstructures and nanostructures on the API and Carrier surfaces.
The shear conditions applied to the pharmaceutical blends was varied by adjusting the level of
the intensifier bar during the blending cycle for the pharmaceutical formulation. The chosen
levels of intensifier bar intensity provided varying levels of shear to the powders at two chosen
levels of significance for this study. A low shear condition of 500rpm and a higher shear
condition of 1000rpm was chosen for the experimental design. The changes in powder
properties and surface topography throughout the various blends can be attributed to formations
of nanostructures as a response to the input variable mix conditions. Nanostructures formed
during the blending of ingredients will be characterized using techniques of Inductively Coupled
Plasma Mass Spectroscopy (ICPMS), Gravitational Displacement Rheology (GDR), and
Scanning Electron Microscopy (SEM). The uniformity and extent of coverage of coating on the
particle interface then controls the responses of powder flowability and powder dilation.
Utilizing Electron Dispersive Spectroscopy (EDS) equipped on a Variable Pressure SEM, this
research focused on qualitatively characterizing the smearing area of the metallic elemental
components of the lubricant (Mg) and glidant (Si) measured across scanned particle surfaces.
The total concentration of these elements in the nanosmears, which have been developed across a
known amount of sample can then be measured using an ICPMS. The powder flowability and
dilation responses were then assessed in GDR. A concept map depicting this methodology is
given in Figure 2.
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Figure 2: Concept Map for Experimental Design
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4. EXPERIMENTAL TECHNIQUES
4.1
4.1.1

Materials and Sample Preparation

Batch Preparation of the Pharmaceutical Powders
Assessment of nanosmear formation among varying mixing orders was studied

using an Acetaminophen (APAP) formulation for the production of tablets. In the
formulation used, the preblend for all conditions comprised a single excipient,
microcrystalline cellulose (MCC) (FMC – Avicel PH102, particle size 100 µm nom.),
and 9 wt% of the active pharmaceutical ingredient (API), Acetaminophen (Mallinckrodt
particle size – 38 µm). Flowing agents added to the preblend included a lubricant,
magnesium stearate (MgSt, Hyqual, particle size 35 µm) and a glidant, fumed colloidal
silica (CS, CABOT Cab-O-Sil grade M5-P, particle size 0.2-0.3 µm). For this study, the
powders were mixed under consistent shear and mechanical strain while mixing order
(M.O.) of the blends was varied. The goal of this study was to experimentally study the
significance mixing order of pharmaceutical ingredients has on nanostructure formation.
Pharmaceutical blends were prepared in a Patterson-Kelly Model B V-Blender
where conditions of intensifier setting, drum revolution, and shear strain will be carefully
maintained for the experimental conditions. Using predetermined calibrations for
intensifier speed and shell speed, experimental parameters will be established that
maintain constant shell speed of 12 rpm. Experimental conditions will then comprise
adjusting the intensifier setting between shearing intensities of 500rpm and 1000rpm.
These mixing conditions will then be applied to four categories of batches, where mixing
order will be the independent variable of study. For the experimentation, the effect of
mixing order of pharmaceutical ingredients will be studied where (M.O.1) lubricant and
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glidant is added to preblend formulation together [B1 and B4], (M.O.2) glidant is mixed
with the preblend followed by the lubricant [B5 and B8], (M.O.3) lubricant is mixed with
the preblend followed by the glidant [B9 and B12], and (M.O.4) only lubricant is mixed
with the preblend [B15 and B16]. The control for the experiments will be B17, which
contained the preblend formulation (Avicel and APAP) only. The breakdown of
compositions of each ingredient comprising the pharmaceutical blend is referenced in
Table 1. In a separate parameter of study, the scale dependency of the flowing agents
will be assessed by a homogeneous decrease in flowing ingredient.
Table 1: Experimental Conditions
Intensifier
Bar [rev]

500

1000

COND

Mixing Order

Avicel [g]

B1
B4
B5
B8
B9
B12
B14
B16
B17
B1
B4
B5
B8
B9
B12
B14
B16
B17

Preblend + (Cab-O-Sil + MgSt) (Together)
Preblend + (Cab-O-Sil + MgSt) (Together)
Preblend + Cab-O-Sil (First) + MgSt
Preblend + Cab-O-Sil (First) + MgSt
Preblend + MgSt (First) + Cab-O-Sil
Preblend + MgSt (First) + Cab-O-Sil
Preblend + Cab-O-Sil
Preblend + MgSt
Preblend Only
Preblend + (Cab-O-Sil + MgSt) (Together)
Preblend + (Cab-O-Sil + MgSt) (Together)
Preblend + Cab-O-Sil (First) + MgSt
Preblend + Cab-O-Sil (First) + MgSt
Preblend + MgSt (First) + Cab-O-Sil
Preblend + MgSt (First) + Cab-O-Sil
Preblend + Cab-O-Sil
Preblend + MgSt
Preblend Only

2256.25
2237.5
2256.25
2237.5
2256.25
2237.5
2262.5
2250
2275
2256.25
2237.5
2256.25
2237.5
2256.25
2237.5
2262.5
2250
2275

APAP Cab-O- MgSt Avicel APAP Cab-O- MgSt
[%]
[%] Sil [%] [%]
[g] Sil [g] [g]
225
225
225
225
225
225
225
225
225
225
225
225
225
225
225
225
225
225

6.25
12.5
6.25
12.5
12.5
25
12.5
0
0
6.25
12.5
6.25
12.5
12.5
25
12.5
0
0

12.5
25
12.5
25
6.25
12.5
0
25
0
12.5
25
12.5
25
6.25
12.5
0
25
0

90.25
89.5
90.25
89.5
90.25
89.5
90.5
90
91
90.25
89.5
90.25
89.5
90.25
89.5
90.5
90
91

9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9

0.25
0.5
0.25
0.5
0.5
1
0.5
0
0
0.25
0.5
0.25
0.5
0.5
1
0.5
0
0

0.5
1
0.5
1
0.25
0.5
0
1
0
0.5
1
0.5
1
0.25
0.5
0
1
0

The past work (K. Pingali et al., 2013b), has shown that homogeneity of the
nanosmearing layer was best seen in the blends where the concentration of flowing
ingredients will be increased together rather than pronominally increasing one flowing
agent’s concentration over the other. In the present work, the studies will test the effect
of nanosmearing from high concentrations of flowing agents in the pharmaceutical blend
consisting of 0.5 wt% CS and 1 wt% MgSt, with the exception of blends B1, B5, B9, and
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B15 where the concentration of flowing ingredients was maintained at 0.25 wt% CS and
0.5 wt% MgSt.
The manner at which flowing agents are added to the preblend is important. In
the industry, typically ingredients are dry milled to a uniform particle size prior to
blending. Since a lack of dry milling equipment was available, hand milling the
ingredients consisted of passing ingredients through a 20 mesh stainless steel screen to
filter out agglomerates of a particular flowing agent in the mix. This ensures a uniform
blend in the final mix. Strain conditions were controlled in 10 minute intervals. The
preblend formulation comprising the API and carrier was allotted 10 minutes for initial
blending. Flowing agents were added to the preblend formulation. In instances where
one flowing agent was added first, a 10 minute strain period was given at high shear to
allow the flowing agent subsequent time to mix with the preblend. The second flowing
agent according to the design of experiments was then added subsequently for another 10
minute strain period to allow enough time for mixing. In instances where two flowing
agents were added simultaneously to the preblend, a 20 minute strain period was given.
The total mixing time, including the preblend, across all formulations was no more than
30 minutes.

4.1.2

Preparation of Pharmaceutical Powders for ICPMS
Samples of pharmaceutical blends collected from the above mixing conditions

were prepared for Inductively Coupled Plasma Mass Spectroscopy (ICPMS) analysis by
dissolving the metallic ions from the thin film nanolayer into a nitric acid and hydrogen
peroxide solution with a refined microwave digestion protocol. While APAP is readily
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soluble, its carrier Microcrystalline Cellulose (MCC) is not. Since 90% of the
formulation used in this study is comprised of a carrier, MCC has to be broken down to
release the metallic ions present in is nanosmeared layer. The ions of interest are
Magnesium, decomposed from the Magnesium Stearate, and Silica, decomposed from
Cab-O-Sil in the nanosmear layer. Samples were completely dissolved in a nitric acid
matrix, then further diluted with millipore purified water to a target solution
concentration of 100ppm for the analysis through the ICP. Internal standards of Lithium,
Scandium, Yttrium, and Indium were added to each sample to check for consistency and
correct for drifts in the analysis of the Magnesium and Silicon ion concentrations. Since
ICPMS relies on comparing the count of a particular ion with a calibration of counts
achieved from known concentrations of a pure element, standards of Magnesium and
Silica were prepared at target concentrations of 1000ppm, 500ppm, 250ppm, 125ppm,
62.5ppm, 31.25pom, 15.625ppm, 7.8125ppm, and 3.90125ppm in a nitric acid matrix
with internal standards above. Figure 3 below shows the preparation of samples for
analysis during the setup of the developed Microwave digestion protocol.

Figure 3: ICP Sample Prep
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4.2

Methods

4.2.1 Qualitative Identification of Nanosmear Distributions
The modification of the Scanning Electron Microscope (SEM) has allowed for the
advancement in characterization tools necessary to study nanoparticles and their
interactions. To analyze the pharmaceutical particles and characterize their nanosmears,
Environmental Scanning Electroscopy (ESEM) coupled with Energy-Dispersive X-ray
Electroscopy Spectroscopy (EDS) was employed.
Distributions of the MgSt and CS components will be qualitatively assessed by
electron density mapping regions of identified elemental detection on top of an acquired
ESEM image. Mappings of the individual elemental components representing the MgSt
and Si will be acquired with an AOI encompassing 100+ Excipient and API particles.
Combining these overlays with the ESEM image, AOI will be calculated with NIH
ImageJ Histograms. Highlights of elemental distributions across the particle surfaces,
representing the presence of the primary elemental component of the nanosmear, will be
counted and compared against ImageJ histograms to provide representative smearing data
across numerous particles of varying shape and size. An example of the ImageJ
capability is shown in Figure 4.

4.2.2

Quantification of Nanosmear Chemical Composition
Inductively Coupled Plasma Mass Spectroscopy (ICPMS) was used to provide

quantitative analysis of the concentration of nanostructures present on primarily the
excipient particles. The ICPMS equipment takes a collected sample and generates an
aerosol of the sample which is then introduced into argon plasma to dissociate the
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Figure 4: ImageJ Analysis of Nanosmear Area

molecules. The instrument removes an electron from the metallic elements and counts
the frequency of a specific ion/isotope. This count is then compared to a developed
calibration curve from known concentrations of the trace elements of interest and
reported in terms of a ppb concentration. A few elemental isotopes for the magnesium
ion and silicon ions were measured in the created standard solutions. Of those isotopes
measure, shown in Figure 5 through Figure 8, the best calibration curves showing the
greatest accuracy at lower concentrations of standard solution were isotopes 26 of Mg,
and 28 of Si. During the experimentations, the ThermoFisher Scientific software
accompanying the instrument automatically applied the chosen calibrations to the ion
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count measured in the samples. This provided a measurement reported in parts per
billion of concentration for detected ions of Magnesium and Silicon.

Figure 5: ICPMS – 24Mg Ion Concentration Calibration

Figure 6: ICPMS – 26Mg Ion Concentration Calibration

Figure 7: ICPMS – 28Si Isotope Concentration Calibration
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Figure 8: ICPMS – 29Si Isotope Concentration Calibration

The trace analysis provided by the ICP measured concentration was converted
into a weighted average using stoichiometry and average physical properties of an Avicel
particle. Since analysis of the Cab-O-Sil coating layer requires detection of Silicon,
which presents multiple mass interferences in the sample analysis, the Collision Cell
Technology (CCT) operation of the ICPMS provided improved accuracy and
quantification of the Silica component on the Avicel particles. Figure 9 showcases the
Thermofisher X-Series ICPMS, rented for use through the cooperation of the QBIC
group and Dr. Keith MacRenaris at Northwestern University.

Figure 9: ICPMS – Thermofisher X-series
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4.2.3

Gravitational Displacement Rheology
Characteristics of the flow properties for each prepared blend will be measured by

two techniques associated with the Gravitational Displacement Rheometer (GDR): the
powder flow index under dynamic changes in powder density and dilation of the packed
powder bed in a simple drum tumbler. The validation and operation of these methods
have been detailed extensively in previous publications (Faqih et al., 2006; K. C. Pingali
et al., 2009). The pharmaceutical powder is loaded into a drum to 50% capacity for the
analysis. The powder is then compacted on the drum’s horizontal axis in an AutoTap Tap
Density Analyzer for 1000 taps. The compacted powder is placed on the GDR and
rotated at a constant speed of 15 rpm. The expansion of the compacted powder bed was
captured by an IR Camera, where the change in expansion by the powder was recorded
for every half rotation and calculated by the software. Since the Dilation of the powder
was uniform across the length of the drum, the software assesses the dilation of the bulk
powder as that seen at the front end of the cylindrical drum. The Flow Index for each
powder will be assessed by rotating the powder at rotational drum speeds of 5, 10, 15, 20,
and 25 rpm. At different rotational speeds, the drum placed on a calibrated load cell
picks up fluctuations in the moment of inertia of the powder bed caused the avalanche
force of the bulk powder. The changes in avalanching pattern and load variability on the
load cell increase when high cohesion from powder agglomerates are predominant in the
powder. When cohesion tendencies of the bulk powder are less predominant, the
variability of force on the load cell is less predominant. A more detailed explanation of
the experimental setup and methodology is described in detail by Alexander et al
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(Alexander et al., 2006). The setup to measure powder flowability and dilation is shown
below in Figure 10.

Figure 10: GDR Setup for Powder Flowability and Dilation

4.2.4

Mercury Porosimetry of Tablets
Porosimetry was assessed on select samples using an Hg Porosimeter. This test

compares the intrusion volume of mercury into a sample at low and then high pressure to
calculate the average pore size distribution of different poor structures based on forcing a
non-wetting fluid, mercury, into a restricted pore volume on the sample surface.
Incremental Intrusion of a non-wetting agent into the porous network of compressed
grains comprising the tablet will provide the distribution of micropores and nanopores in
the sample. This network of pores results from existence of varying levels of molecular
and electrostatic forces generated from the domination of confined zones or smearing
area of MgSt on the particle surface. Mercury Porosimetry correlates incremental change
in intrusion volume of Mercury with applied pressure utilizing Washburn’s Theory to
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estimate equivalent pore diameter (Westermarck, 2000). The results from this
assessment will allow for the understanding of changes in microstructure with smearing
of flowing agents.

4.2.5

Dissolution of Tablets
Prior to performing the Dissolution testing, the UV-Vis Spectrophotometer

required a calibration curve to correlate measured UV absorbance to a known
concentration of APAP in the required buffer for the Dissolution of APAP Tablets
protocol. A line scan of a solution of APAP dissolved in a Phosphate Buffer of PH of 5.8
was performed to determine the peak absorbance concentration of APAP. The peak
absorbance of APAP was measured to be at a wavelength of 243.5nm, which corresponds
closely to absorbance values documented in the literature. Once the peak absorbance was
found, several diluted concentrations of APAP in a phosphate buffer ranging from 0.52
ppb to 33.33 ppb were measured for their UV absorbance values at a peak absorbance
wavelength of 243.5nm. The line scans of wavelength versus UV absorbance are shown
below in Figure 11.

Figure 11: APAP Standardization Curves – Scanning Multiple Wavelengths for Peak
APAP Absorbance
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Using software provided by Agilent, the peak absorbance values measured at the
wavelength of 243.5nm were correlated to the known concentrations of the various
solutions of APAP used in the calibration. A linear relationship, as shown in Figure 12,
correlating the absorbance value to the known calibration standards was then used to
calculate the concentration of APAP during the dissolution of tablet over the testing
interval.

Figure 12: APAP Standardization of UV Absorbance with Concentration

Pharmaceutical blends were prepared in the V-Blender, compacted with an MCC
MP-10 Tablet Press under compression forces of 8kN and 12kN, and tested for drug
release using a USP configured DS708 Dissolution Apparatus from Agilent. The purpose
of producing tablets was to provide a preliminary proof of concept to associate changes in
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product performance with altercations in nanosmear attributes across particle surfaces in
select blends. Dissolution of Acetaminophen tablets was performed according to USP
Monographs in a phosphate buffer solution of pH 5.8 for 90 minutes (Pharmacopeia,
2007). Drug release profiles of the active ingredient Acetaminophen from 6 tablets were
simultaneously measured using a Cary 60 UV-Vis Spectrophotometer from Agilent.
Dissolution rate of the Acetaminophen tablets in the six vessels was calculated from
absorbance information collected from the individual vessels compared against the blank
and saturated solutions. A depiction of the equipment used to perform the Dissolution
testing is shown in Figure 13.

Figure 13: USP Agilent 708 UV-VIS Dissolution Apparatus

4.2.6

Design of Experiments Statistical Analysis
To assess the statistical correlation and relationships between parameters of

mixing order, shear intensity, and glidant/lubricant scale, the experiments are arranged in
a random 2k factorial design, as shown in Table 2, which can be assessed for statistical
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significance of factor interactions in ANOVA. However, since not every factor can be
appropriately represented in our DOE, the choice to utilize a two level fractional factorial
based design was chosen. This would allow the variations in uniformity, extent of
coating, and characteristic nanostructure formation in the powders to be studied as multivariant parameters which hypothetically have significant interactions on tablet
performance and bioavailability. The support of statistical design to validate the
significance and interaction with the factors discussed in this DOE has wide applications
for quality control and product performance validation in bio-medicine manufacturing.
Providing statistical validation and direction as to which combination of effects has the
most significant influence on product quality forms will help Pharmaceutical
Manufacturing optimize current inefficiencies and improve their overall Quality by
Design.

Table 2: Statistical DOE

Run
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Order of Lubricant
Conc
Mixing
-1
1
-1
-1
1
1
1
1
1
-1
1
1
1
-1
-1
1
-1
-1
-1
-1
-1
-1
-1
1
1
-1
-1
1
1
1
1
-1

Shear
1
-1
-1
-1
-1
1
1
1
-1
1
1
-1
1
-1
1
-1

2k Factorial Design
Compres
Flow
Dissoluti
Hardness
Dilation
sion
Index
on
1
x
x
x
x
1
x
x
x
x
1
x
x
x
x
-1
x
x
x
x
-1
x
x
x
x
1
x
x
x
x
1
x
x
x
x
-1
x
x
x
x
-1
x
x
x
x
1
x
x
x
x
-1
x
x
x
x
1
x
x
x
x
-1
x
x
x
x
-1
x
x
x
x
-1
x
x
x
x
1
x
x
x
x
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%Area
CS
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

% Area
MgSt
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Conc.
CS
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Conc.
Mg
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

5. RESULTS
5.1

Nanosmearing Layer Characteristics Due to Mixing Order of Ingredients

The formation of nanosmears at the contact particle surface formed during shear of
flowing agents in the pharmaceutical blend create an unique understanding in the
application of addressing scale up variables in the processing of pharmaceutical powders.
In Figure 14, localized clusters of nanosmears form different characteristic structures
with different orders of mixing. The different size distributions of nanosmears being
formed on the particle surface provide evidence that surface characteristics of the
nanosmear govern the growth, distribution, and development of the nanosmear layer
during mixing. The physical structure of the nanosmear created when flowing agents are
deposited to the excipient particle surface is influenced by the size and yield strength of
the flowing agent during mixing. The flowing agent Cab-O-Sil is an agglomeration of
nanoparticles with low yield strength that deposit a cluster of the agglomeration during
contact friction with the excipient particle surface. The lubricant MgSt is a highly friable
platelet with low yield strength that transfers a portion of its mass to the thin-film
nanolayer when contact friction with the excipient particle surface is experienced. The
strength of these layers has shown that CS formed a much stronger layer to the particle
surfaces, while the thin-film nanolayer of MgSt is very weak and friable to shear friction.
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Figure 14: Different Nanostructures Formed as Result of Mixing on Carrier Particles

When the mixing order of flowing agents was altered during the experimentation,
different characteristic developments in nanosmear size were seen, as shown in Figure
15. The histograms shown relate two cases: (Figure 15a) blends mixed with a low
concentration of flowing agents (0.25 wt% CS and 0.5 wt% MgSt) and (Figure 15b)
blends mixed with a high concentration of flowing agents (0.5 wt% CS and 1.0% MgSt).
In cases where the flowing agents were added simultaneously during mixing (B1 & B4),
nanosmears showed a greater distribution in size across the excipient surface. Increasing
the flowing agent concentration in the blend during mixings indicates that the presence of
these additional ingredients increase the size of the smear formed on the excipient surface
and their distribution in smear size. In the batches where CS was mixed with the
preblend first (B5 & B8), nanosmears were observed to have a rougher surface texture on
the excipient particle surfaces, mostly due to the deposits of CS nano-agglomerates.
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Figure 15: Distribution of Nanosmears on Carrier Particles Formed During Mixing

These particular nanosmears were bigger in size and shape on the excipient surface,
having a size distribution between 0.5-1000 µm2. Increasing the concentration narrowed
the distribution of observed smear size slightly, but the average smear size was more or
less the same with an increase in flowing agent concentration in the blend. A very
interesting observation in nanosmear size distribution was seen in the blends where CS
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was added after the addition of MgSt to the preblend (B9 & B12). More predominate
clusters of CS agglomerates were seen to have bound to the base MgSt nanolayer,
creating smaller nanosmears, but with a smaller distribution in smear size. The increase
of flowing agent concentration was seen to significantly reduce the size distribution of
the measured smears, indicating the predominance of similar size and shape smears
across the particle surface. It is reasonable to conclude that this order of mixing creates
potentially a more porous smeared layer, as smears formed from this mixing order were
less frequently overlapping and covering large areas of the excipient surface. When only
MgSt was added to the preblend during mixing (B15 & B16), the base thin film
nanolayer was observed to be uniform, showing smeared deposits of MgSt across the
excipient particle surface.
Interestingly, it is clearly evident when only MgSt is added to the blend, the smear
size distribution remains more or less the same. While the average smear size was seen
to increase slightly with an increase in MgSt concentration, the distribution of nanosmear
size on the excipient surface is not dependent on concentration. This outlines a critical
interaction that the flowing agent Cab-O-Sil plays in the rearrangement and structure of
the nanosmear layer during mixing, which will be explored in future works. Additional
applications for enhancing the understanding of nanosmear formations are the influence
that concentration has on the formation of nanosmears. Controlling concentration was
seen to control the distribution in smear size on the excipient particle surface. This
presents an interesting key towards understanding the necessity of controlling nanosmear
size distributions for a promising application of optimizing physiochemical performance
of pharmaceutical blends and tablets.
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Stepping backward to the macro scale, particles of the ingredients comprising the
pharmaceutical blend will interact to form different distributions and densities of
nanosmears. Analysis of multiple particles under an ESEM with the X-Ray Mapping, as
shown in Figure 16, highlights noticeable differences in electron density distributions.
These differences in flowing agent density amongst the scanned particles underline
unique frequency distributions arising from the mixing of ingredients. Different orders of
mixing have shown a buildup of agglomerates and areas of non-uniform distribution in
the electron density for certain conditions in the maps, emphasizing the need to
characterize the significant differences in nanostructures formed from flowing agent
coating of the Preblend. Non-uniform distributions of flowing agents across the excipient
and API particle surfaces are greatly seen in M.O.3, where MgSt was mixed with the
preblend first. For M.O.2, where CS was mixed with the preblend first, agglomerates of
CS on the particle surface created cluster zones where MgSt would also cluster in the
nanolayer. It is believed that these clusters are very hydrophobic in nature, which can
possibly attribute to high impediments in drug release characteristics seen in the
compressed tablets for that particular mixing order. While the present work is not
sufficient to explain why scale up issues and product batch failures from improper mixing
occur, these regions of high concentration of one flowing agent over the other create
predominant interparticle interactions that catastrophically affect blend cohesion and
tablet tribological behavior, which will be explained further.
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Figure 16: Effect of Mixing Order on Electron Density Patterns

5.2

Area Mapping Nanosmears

Singular particle analysis is useful for understanding the characteristics of
nanostructures, but the variability of particle shape and size distributions will create
different levels of nanosmearing on other particle surfaces. In this context, the technique
to correlate area distribution of nanosmears on multiple particles from their electronic
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patterns obtained through EDS micrographs were developed. EDS micrographs were
masked to confined particle boundaries obtained from the ESEM image. Using NIH
image histograms, localized clusters and confined pixels identified from the EDS
mapping were counted and compared against the total area for each particle. This
comparison was then used to collect an average of the extent of nanosmears for CS and
MgSt across the particles outlined from the ESEM image. The results of smearing area of
CS and MgSt for different blends are shown in Table 3.
Table 3: Results of ICP and ESEM-EDS Nanosmear Quantification
ng CS / Smear
ng MgSt mg CS /
mg MgSt ICP
ICP CS
Area
particle
gm
MgSt / particle
Group
/ gm
StdDev
Avicel %MgSt
Avicel
Avicel StdDev Avicel
B1
6.47
0.21
6.29
1.97
0.10
1.91
28.7
B4
12.84
0.41
12.48
3.66
0.17
3.56
32.3
B5
6.84
0.20
6.65
3.03
0.00
2.94
28.0
B8
12.10
0.18
11.77
2.75
0.10
2.67
34.0
B9
3.52
0.09
3.43
2.42
0.07
2.35
34.0
B12
4.43
0.12
4.30
0.98
0.04
0.96
37.9
B15
6.29
0.20
6.12
2.01
0.11
0.00
30.35
B16
10.64
0.32
10.35
2.39
0.07
0.00
32.74
B17
0.00
0.00
0.00
0.00
0.00
0.00
0.0
B17
0.00
0.00
0.00
0.00
0.00
0.00
0.0

5.3

MgSt
Error
9.3
9.3
7.9
7.8
8.8
7.9
6.41
8.57
0.0
0.0

Smear
Area CS Error CS RSD
%CS
32.5
37.2
10.6
28.6
28.9
38.8
8.5
22.0
28.1
34.9
8.2
23.4
22.8
39.4
8.3
21.0
25.9
38.4
10.1
26.2
20.9
44.9
8.0
17.9
21.11
0.00
0.00
0.00
26.18
0.00
0.00
0.00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

MS RSD

Flow
Index
50.4
40.0
38.7
34.2
37.1
32.6
33.73
32.50
23.6
23.6

Weight of Characteristic Nanosmears

The amount of nanosmear was measured using ICPMS technique previously
discussed to identify the elemental concentrations of Mg and Si in the nanolayer. This
technique helps illustrate the scale dependency of nanosmear formations as they impact
macro scale physiochemical characteristics in the solid dosage form. From Table 3, it
was seen previously in M.O.3, where MgSt was added to the preblend first during
mixing, that the extent of nanosmears from processing created the greatest coverage of
both following ingredients on pharmaceutical particle surfaces. However, the ICPMS
analysis indicates that the concentration of ingredients in the thin film nanolayer is the
least, providing insight into the strength and stability of the nanolayer formed from
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Dilation
8.8
17.6
5.0
22.9
26.0
31.7
20.50
23.60
20.7
20.7

M.O.3. When all flowing agents were mixed together (M.O.1) and when CS was added
to the preblend first (M.O.2), the greatest concentrations of flowing agents was present in
the thin film nanolayer. The relationship between the extent of smearing and the
concentration of nanosmears on particle surfaces emphasizes a critical link to the design
of solid dosage forms that will be experimentally supported and explained in future
sections.

5.4

Critical Blend Properties

Flowability and dilation testing has shown that applied mechanical strain from
varying the mixing order of flowing agents with the preblend formulation was a dominant
factor in changing the physical behavior of the bulk powder (K. Pingali et al., 2013a).
Flowability and dilation assessments of the bulk powder were measured using a GDR
apparatus detailed in the experimental section above. The analysis performed highlights
differences in the flowability of the blend when varying mixing orders of the ingredients
were prepared with flowing agent concentrations of 0.25 wt% CS & 0.5 wt% MgSt
(Figure 17a) and 0.5 wt% CS & 1.0 wt% MgSt (Figure 17b). Assessment of the flow
index by characterizations of the variation in avalanching force is a proven tool to
understand cohesive properties of the pharmaceutical blend (Alexander et al., 2006). In
this context, the greatest cohesive properties of the blends was ranked in blends B1, B4,
B5, and B9. The blends exhibiting the least cohesive properties in order of decreasing
cohesive properties was seen in blends B8, B15, B12, and B16. It is interesting to note
that mixing flowing agents together simultaneously created powders exhibiting the
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greatest cohesive properties. Only blends that were mixed with the lubricant, MgSt,
exhibited low cohesive properties to provide better powder flowability.
The measure of dilation as a tool to characterize the powder’s elastic recovery from
a compacted state was used to understand the material response capabilities of the
powder. Dilation of each powder was measured for blends containing a low concentration
of flowing agents (Figure 17c) and a high concentration of flowing agents (Figure 17d).
Given the two concentrations of flowing agents used in the preparation of the powders,
the ranking of material response due to mixing order showcases that batches mixed
according to the M.O.1 and M.O.3 schemes had the least and greatest potentials for bed
elastic recovery, respectively. The dilation response of powders is a critical factor in
maintaining blend uniformity during the processing of pharmaceutical powders, which
will be discussed in the subsequent sections.

Figure 17: Flowability and Dilation of the Powders
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5.5

Compacted Tablet Physicochemical Properties

Unique nanosmears formed during mixing created different microstructure
arrangements in the porous tablet matrix (Figure 18a and Figure 18b). While ESEM
images are not shown, compaction of the powders rearranged the excipient and API
particles in a matrix best suiting the intermolecular stability of the system. Increasing the
compression force to 12kN in the powders was seen to migrate nanoparticulate
remainders of the flowing agents to the surface of the solid dosage form, thereby creating
localized clusters to impart tablet porosity and drug release. At low compression forces,
the pharmaceutical tablets showed a greater porous network when CS was added to the
preblend first (M.O.2). A large microporous network is also seen in blend B16 (M.O.4)
with just MgSt in the nanosmear layer. When compacted, the materials were rearranged
to form tighter nanoporous structures, with the exception of the B16 where MgSt
nanosmears predominate the surface of the particles. The distribution of pore diameters
in the tablet matrix for blend B16 was confined to the micropore region, even after
increasing tablet compaction, indicating that the glidant is responsible for particle
interactions and rearrangement of tablet microstructure.
The rearrangement of tablet microstructure will essentially control the kinetics for
release of the active ingredient from the tablet matrix (Figure 18c and Figure 18d).
Amongst two different levels of tablet compaction force, drug release was least hindered
for blends where the flowing agents were mixed together simultaneously. The rate of
release of APAP into the buffer solution was hindered the greatest in formulations B8 and
B12 where flowing agents were mixed individually into the blend. Amongst all both
conditions, the ranking of the kinetics for drug release for two levels of compaction force
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remained the same. The association of both porosimetry and dissolution assessments
with characterized formations of nanosmears provide a unique insight into tablet
physiochemical behavior, which will be discussed in greater detail.

Figure 18: Effect of Mixing Order on the Physiochemical Properties of Compressed
Tablets
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6. DISCUSSION
6.1

Extent of Nanosmearing by Area Distribution

Nanosmearing forms unique nanoparticulate surface structures that alter the
distribution of flowing ingredients and surface characteristics of the particles. Therefore,
the extent of nanosmearing is not only dependent on mixing order but potentially on the
concentration of the formulation. Past work has shown that increasing the concentration
of one flowing agent over another in the pharmaceutical blend has shown clusters of
nanosmears that create the non-even distribution of flowing agents in the nanolayer (K.
Pingali et al., 2013b). During smearing, no particle can be 100% smeared by a flowing
agent due to the friability of ingredients, porous characteristics, and physical morphology
at the particle surface. Since excipient particles are known to have varying shape and
size distributions, no two excipient particles will smear the same. The same can be said
for varying size distributions of the API particles as well. Therefore, refinement of
techniques to interpret the extent of smearing and amount of smearing amongst multiple
particles that govern a pharmaceutical formulation’s tribological behavior is a necessary
endeavor for future works.
The largely quantitative differences in smearing extent previously shown from the
variation in processing mixing order of flowing agents supports a few important
conclusions. First, it is supported that the evenness of distribution of flowing agents is
the best when flowing agents are added together simultaneously in the mixing process.
Second, the flowing agent CS, which is known to interact with the flowing agent MgSt, is
most effective in increasing particle smearing when it is added after MgSt has been
mixed with the Preblend. While MgSt is highly friable with shear to coat the particles,
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given the lesser extent of smearing when it is the sole ingredient (M.O.4), it is evident
that CS creates stronger bonds to MgSt and the particle surface that hold against
interparticle shearing friction during mixing. The results suggest that the extent of
smearing is dependent on a possible reorientation of nanostructures in the nanolayer from
changes in the mixing order. Reorientation of nanostructures allow for different spatial
configurations of particles during packing, giving compressed powders unique categories
of void volumes which would affect tablet performance properties, such as hardness and
dissolution. If this true, the phenomenon of nanosmear structural reconfiguration, which
is not completely understood, could be a key mechanism to controlling surface properties
that spark interparticle interactions. An enhanced improvement in methodology would be
needed to interpret particle interactions in a physically reasonable way. Whether
smearing of flowing agents during mixing creates singular layers or a multi-layers on the
particle surface, and whether the thickness of these layers across varying particles is
similar, is not yet known. However, it is intuitive to argue that the surface density of the
nanosmeared layer plays an important role in the stability of the thin-film nanolayer
against particle collisions and friction.

6.2

Quantification by the Weight of Nanosmearing

The extent of nanosmearing on the particle surface for various blends provides an
insight into the variability of nanosmears across pharmaceutical particles. However, the
amount of nanosmear ingredients MgSt and CS is equally important to visualize the
thickness of nanosmear deposits on the particle surfaces. These results previously shown
in Table 3 stress that the formation of nanosmeared structures are time dependent during
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the mixing process, which underline the importance of shear strain on the formation of
these nanosmears with varying mixing conditions. Surprisingly, different mixing orders
have shown that increased coverage of the nanosmear does not increase the amount of
nanosmear on the particle surface. In this sense, we experimentally demonstrate that
nanosmear structures change as a function of the extent of distribution on particle
surfaces.
The extent of nanosmear coverage with respect to their measured mass in the
nanolayer is shown in Figure 19a. There exists a clear correlation between the weight of
the nanosmear and its coverage in the thin-film nanolayer. Interestingly, the weight of
the nanosmear flowing agent deposited on the particle surface is inversely related to the
extent of particle coverage by the correlating nanosmear component. Larger weights of
nanosmear are seen to provide less coverage of the particle surface, indicating that higher
concentrations of the flowing agents preside in the nanolayer but do not necessarily
create an extensive particle coating.

Figure 19: Relationship between Smeared Area vs Smear Layer Composition
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Although M.O.3 showed electron density regions of heavily clustered agglomerates
of CS with a far greater extent coverage in the nanolayer, the lack of flowing agent
presence in the nanolayer from the ICPMS support that the bonding of MgSt to particle
surfaces is very weak and most likely wears away, decreasing the nanolayer thickness,
due to particle friction during mixing. Amongst the different smears formed, MgSt
nanosmears were seen to cover less of the particle surface with a greater mass in the
nanolayer. The smears formed by CS on the other hand had a greater extent of coverage
on the particle surface with less mass given the size and structure characteristics of the
smear they form. For the two concentrations of flowing agents used in this study,
increasing the flowing agent concentration was seen to systematically increase smear
coverage and weight on the particle surfaces. In this context, it is necessary to control the
concentration of flowing agents in the processing of pharmaceutical powders. It is
important to note for future discussion that smearing that exceeds roughly 33% of the
particle surface has severe consequences to the tribological performance of manufactured
tablets. While this article doesn’t propose an effective means to chemically control the
formation of nanosmears and their distribution in particle surfaces, it is evident that the
first step to controlling nanosmearing on particles can be achieved by controlling the
order and concentration by which flowing agents are blended.
Controlling the rate of nanosmear formation is a missing link and an underestimated
consideration in the processing of pharmaceutical powders for the manufacture of solid
dosage forms. What is a greater unknown is the mechanism by which particles of
different shapes and sizes can effectively contain consistent smears of flowing agents in
their coating. The variability in the extent of nanosmears was seen to be significant from
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blend to blend, and the mixing order of flowing agents was a factor on the variation of
smearing. An increase in nanosmear weight on the particle surfaces was found to
increase the relative standard deviation in the extent of nanosmears across multiple
particle surfaces in Figure 19b. It is intuitive to argue that smear weight directly
influences nanosmear layer stability. As a larger variance in smear area is seen with
higher masses of nanosmears on the particle surfaces, this particularly presents the case
that nanosmears grow in the nanolayer to a certain extent before they break off the
particle surface from particle collisions arising during mixing to create gaps in the thinfilm nanosmear layer. However, the problem of characterizing indirect deformations to
the thin film nanolayer due to ordered mixing has not been solved and will be addressed
in future works.

6.3

Bulk Powder Property Response Due to the Mixing Order of Ingredients
Material response properties of the powders are dependent on interparticle

interactions taking place at the particle surface, so it is intuitive to conclude that changes
in particle surface chemistry will impart different responses to the macro scale. An
incremental increase in cohesive properties from simultaneous mixing of flowing agents
versus improved flowability through individual mixing of flowing agents reflects the
apparent change in interparticle behavior. This arises from physiochemical changes
brought about by unique nanosmear characteristics at the particle surface. Experimental
analysis of the bulk powders in the GDR reveal that the flowability of the powders,
characterized by a Flow Index, show higher cohesive physical tendencies when different
nanostructures were formed. When flowing agents were mixed together (M.O.1), an
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even distribution of the nanosmears and limited extent of nanosmearing showed higher
cohesive tendencies in the GDR, indicated through a higher flow index. The lowest
cohesion in the blend, characterized by a low flow index, was seen when only MgSt was
mixed in the blend where no CS nanosmears were present. When CS nanosmears formed
in the nanolayer they created new nanostructures to alter tribological particle interactions.
It was evident that when CS was mixed first in the blend (M.O.2), the blend exhibited
low cohesion and a smaller smear area of CS. When CS was added after MgSt to the
blend (M.O.3), nanosmears of CS forming on top of nanosmears of MgSt evidently
increased the bulk powder’s interparticle cohesion, evident by a greater flow index. This
marks an interesting phenomenon. Often, the pharmaceutical industry relates high
cohesion of the bulk powder to processing as not having enough lubricant in the blend. If
high cohesion by the development of pronounced nanosmears of CS results in greater
interparticle bonding, then monitoring the level of CS in the pharmaceutical blend and its
mixing are very important considerations during manufacturing. While M.O.3 had the
greatest smearing of MgSt, nanosmears of CS predominating on the nanolayer create
physicochemical changes to the response of the powders when compacted in the tablets,
which will be discussed later in the evaluation of tablet performance.
The formation of nanosmears is seen to influence critical material response
properties of the pharmaceutical blend. It is understood and supported above that
increasing smearing improves bulk flow properties. However, the variability in smearing
is dependent on a wide array of factors, such as different orders of mixing and flowing
agent concentration, which is not easily predicted. In this manner, we experimentally
show how the relative standard deviation of the extent of smearing from particle to

48

particle is related to the flowability of the powder (Figure 20a). A reduction in smearing
variation from particle to particle is seen to enhance the flowability of the powder. The
experimental results show that non-consistent smearing increases the cohesive properties
of the blend. Therefore, choosing the correct concentration and appropriate mixing order
of flowing agents are necessary for the control of the powder’s material response
characteristics.
The elastic recovery of the pharmaceutical powder blend was found to be
proportional to the extent of nanosmear formation across particle surfaces. (Figure 20b).
Through Dilation experimentation performed on the GDR, the Dilation of the bulk
powder is directly proportional to the smearing of MgSt on the particle surfaces. Higher
smearing of MgSt altered contact mechanics between particles to significantly recover
the powder to a less dense bulk state, than blends with less smearing of MgSt. Even with
higher smears of CS on the particle surfaces, which have proven to increase cohesion of
the blend, show that CS smear does not hinder the powder bed’s expansivity. This
indicates that the predominance of electrostatic forces under softly compacted conditions
exhibited by MgSt deter cohesion of the blend. The smearing of MgSt on the particle
surfaces is expected to alter contact mechanics of adjacent particles which ultimately
explain the change in powder bed porosity and volume. From this perspective,
controlling the elastic recovery potential during the processing of the pharmaceutical
powder to maintain blend homogeneity could potentially be controlled through the
smearing applied to the particles.
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Figure 20: Relationship of Nanosmearing with Powder Flowability and Dilation

The weight of the MgSt nanosmear formed from varying orders of mixing at
contact particle surfaces influences the compactability and bulk density of the blend.
Increasing nanosmears improved bulk and compaction densities to an extent, which can
be attributed to the contact mechanics arising from interparticle forces strengthened by
clusters of nanosmears on the particle surface (Figure 21). Increasing the amount of
smearing on the particle surface is shown to improve properties of bulk density when low
concentrations of flowing agent are mixed with the Preblend. Interestingly, an increase
in flowing agent concentration during mixing is observed to significantly improve bulk
and compact densities, but also highlights the critical inflection where excessive
nanosmear weight on particle surfaces reduces properties of bulk density.
Understanding this inflection where material properties begin to adversely change
underlines the necessity to control flowing agent concentration in the pharmaceutical
formulation. Changes in material response have been seen to affect the critical
performance properties of the blends when they were compacted into tablets.
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Figure 21: Relationship of Nanosmearing with Powder Response Properties

When compressed into tablets, the contact mechanics between particles change as a
result of thermomechanical alterations to the microstructure in the form of material
rearrangements and deformations, which will be discussed more in detail in the next
section. Under high compaction forces, new physiochemical bonds and molecular
reorientations will occur, thereby changing critical properties in performance of the solid
dosage form. To understand the change in performance response due to variances in
nanosmeared structures, it was important to assess the performance of solid dosage forms
once the powders were compacted into tablets at a high and low compression forces
(12kN and 8kN).
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6.4

Influence of Nanosmearing on Tablet Porosity

The characterization of the powder microstructure after compaction provides a
better insight as to the particle-particle behavior and rearrangements occurring in the tablet
matrix. The increase in microporosity of the tablet is due to the electrostatic forces resisting
particle interactions caused by the smearing of MgSt on the particle surface (Figure 22).
When translating these porous distribution networks to characterize the bulk porosity of
the tablet, it is evident that higher porosity characteristics were seen when the smearing of
MgSt in the nanolayer increased. However, as one would expect, higher smears of CS in
the nanolayer decreased porosity. This is most likely due to rearrangements in tablet
microstructure from interparticle interactions enhanced by the development of CS
nanosmears.

Higher amounts of CS increased particle smearing of flowing agents,

although this has been seen to directly hinder the release of the API from the excipient
matrix.

Figure 22: Relationship of Nanosmearing with Tablet Porosity
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It is evident that increases in nanosmears, particularly the smearing MgSt across
the particle surface, led to prolonged drug release and increased porosity in the tablets.
This brings us to believe that mutual dependencies between the distribution and amount of
CS and MgSt on particle surface can be critical in determining the product behavior.
Results discussed previously highlight the influence of mixing order on the rate of release
of the active ingredient from the excipient matrix. Previously, it was seen that flowing
agents mixed simultaneously in the blend provide the fastest mechanism of release while
flowing agents mixed separately into the blend create a more complex excipient matrix to
hinder drug release. This phenomenon is most likely the result of excess lubricant
migrating to the caps of the solid dosage form, which can prevent solubilization of the
active ingredient into the buffer media. When drug release was assessed by characterizing
the critical inflection point where release begins to slow, at approximately 21 minutes
(Figure 23), it was evident that the relationship between smearing of MgSt on the particle
surfaces and drug release highlights a critical equivalence point. This critical equivalence
point is seen to be around 33% smearing of MgSt and supports that nanosmearing
exceeding the critical equivalence point has significantly impeded drug release with
increased smearing. This critical equivalence point is also evident from data collected from
the Mercury Porosimetry testing that an increase in coverage of MgSt in the nanolayer
increased the tortuosity ratio characterizing the distance traveled from pore to pore over
the actual distance between pores (Figure 24). An increase in tortuosity in the tablet matrix
slows the solvent penetration rate and increases the time of dissolution for the API.
However, we cannot assume that dissolution is solely dependent on extent of lubricant
covering the nanosmear layer. To provide a qualitative picture as to the greater impact of
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nanosmears on bulk scale behavior, the thickness of the nanolayer, along with the extent
area and amount of ingredient in the nanolayer all need to be completely understood.
The influence of nanosmeared distributions of MgSt on an excipient or API surface
not only influence the chemical dependencies of the product behavior, but also influence
physical attributes of the final product. In this case, we present a study to understand the
impact of these nanosmears on the hardness characteristics of the tablet. It is well known
that increases in concentration of MgSt can create friable tablets. In this respect, increasing
smearing area of the lubricant can weaken the tablet matrix and affect solid dosage
durability. In Figure 25, tablet hardness characteristics were seen to decrease with an
increase in smear of MgSt across the particle surface. However, tablet hardness was
regained at the end where MgSt coverage was the highest primarily due to interactions of
CS nanosmears with the excipient and API to form a stronger matrix. These cases to
correlate the order of mixing of pharmaceutical ingredients have shown that nanoscale
deposits and interactions play critical factors in macro scale performance in both the critical
blend and tablet properties which cannot be ignored.
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Figure 23: Relationship of Nanosmearing with Tablet Tortuosity

Figure 24: Relationship of Nanosmearing Weight with Tablet Hardness
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Figure 25: Relationship of Nanosmearing with Drug Release Properties

6.5

Response of Shear, Mixing Ordrer, and Lubrication on Nanosmearing

From the work previously shown, limiting the nanosmearing of the lubricant MgSt
in the final blended product is detrimental to the solubility, porosity, hardness of the final
drug product. These attributes are a few of several that govern the release criteria for a
drug product. Understanding the combination of effects to limit nanosmearing and
optimize the final release attributes is essential in the formulation and manufacture of a
drug product. In Figures 26A-26C, the extent of MgSt nanosmearing are increased by
increasing lubrication amounts and intensifier shear. However, MgSt smearing was
observed to decrease with increasing mixing time in the V-blender. This supports the
notion that the smeared layer of MgSt is very friable and breaks from the particle surface
with longer periods of mixing.
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Figure 26: Effect of Shear, Mixing Order, and Lubrication Level on Nanosmearing

In Figures 26D-26F, the amount of MgSt nanosmearing on the particle surface is
greatest when the lubrication quantity in the blend is the greatest and mixing time is
minimal. Increasing the shear with the intensifier bar was seen to reduce the amount of
namosmearing on the particle surface, supporting this smeared layer is friable when
subjected to high shear forces. Figure 27A supports that MgSt nanosmearing is
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influenced by an interaction between intensifier shear and mixing time of MgSt, as well
as an interaction between the intensifier shear and lubrication level. The main effects
plots below show there is a statistical significant interaction between shear and mixing
time that could be understood further with future studies into the effects of shear on
nanosmearing.

Figure 27: Main Effects Influencing Nanosmearing
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7. FUTURE WORKS
Understanding the influence of shear and the interaction of the CS nanosmeared
layer with the nanosmearing phenomena of MgSt is necessary to fully understand the
phenomena behind nanosmearing and its influences to blend properties and final drug
product critical quality attributes. As shown in Figure 28, this work found an interaction
between CS nanosmearing and the smearing potential of MgSt. In order to control the
smearing of MgSt in the final blend, controlling the smearing of CS is also essential. To
create the best formulation, minimizing the smearing of CS and MgSt would need to
understand to develop better controls for nanosmearing during the blending of
pharmaceutical ingredients. As shown in Figure 29 and Figure 30, further exploring the
influence of shear on the extent of nanosmearing has shown that at a higher shear rate of
the intensifier bar in the blender, a minimum level of MgSt and CS can be achieved.
Understanding this minimum point of smearing to produce optimum critical quality
attribute results in the final drug product will be the focus of future works.

Figure 28: Relationship between CS and MgSt Nanosmearing
59

Figure 29: Influence of Shear on MgSt Nanosmearing

Figure 30: Influence of Shear on CS Nanosmearing
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8. CONCLUSIONS
From the work, it is evident that understanding the structural characteristics of
nanosmearing development is crucial towards understanding the tribological behavior of
bulk powders and critical tablet properties that affect the final product performance. While
shear was maintained between two levels during the order of mixing in the preparation of
the pharmaceutical blends, the results support that applied shear is a critical factor that
cannot be ignored. Applied mechanical strain on the pharmaceutical ingredients and
flowing agents changed the overall material response characteristics of the particles in
terms of the alteration of cohesive tendencies in flowability, changes in bed expansion
response in dilation, shifts in tablet matrix organization to offset porosity, and the migration
of nanosmeared ingredients to impede drug release.
A detailed nanoscale investigation of the prepared pharmaceutical particles
confirmed that the blending of lubricants and glidants form thin-film nanolayers on
excipient and API particle surfaces. It was clearly evident that the shape and size
distribution of the nanosmears formed on the excipient surface are influenced by both
concentration of ingredients and their order of mixing.

The distribution in size of

nanosmears measured on the excipient particle surface were seen to be the greatest when
only MgSt was mixed into the pharmaceutical preblend. When two flowing agents were
mixed together at low concentrations, the greatest distribution in smear size was seen when
CS was added to the preblend first, while the smallest distribution in smear size was evident
when both CS and MgSt were added to the preblend together. Increasing the concentration
of flowing agents in the blends indicated that the smear size formed on the excipient surface
was the smallest and most consistent in size when MgSt was mixed to the preblend first.
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The difference in size distributions in smear across the excipient particles highlight a
significant importance that mixing order plays in flowing agent interaction to create
structural reconfigurations in the nanosmear layer.
The orientation of these different nanosmears from the various mixing orders in
turn affected physiochemical properties of the tablets, such as porosity, dissolution, and
density. These structural configurations presented by the nanosmears in the coating layer
provide unique insights that explain changes in product performance from mixing. As a
result of mixing the pharmaceutical flowing agents in different orders, nanosmearing of
MgSt was seen to increase when CS was mixed after the addition of MgSt to the
formulation to form more nanosmears across the particle surfaces. Tablet porosity was
seen to increase with an increase in MgSt nanosmearing across the particle surfaces to an
extent where an increase in distribution of CS conformed to areas of the porous network to
most likely fill in void volumes. The rate of release in the tablets was seen to have been
hindered when the amount of MgSt nanosmearing exceeded an identified critical
equivalence point of 33%. Tablet hardness also decreased with increasing amounts of MgSt
nanosmearing across the nanolayer, but the tablets showed indications of strength recovery
from friability when greater nanosmearing of CS was present across the nanolayer. Future
work to enhance the understanding of nanosmears shows great promise, as nanosmear
rearrangements during mixing orders are unique. This makes nanosmear classification and
control a trivial influence in the processing and performance of all pharmaceuticals
manufactured under existing standards and practices.
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